Valuation: DexCom, Inc.

Market Cap 31.07B 28.2B 26.05B 23.52B 44.33B 2,928B 45.89B 313B 124B 1,564B 117B 114B 4,962B P/E 2026 *
32.7x
P/E 2027 * 27.6x
Enterprise Value 30.73B 27.88B 25.76B 23.26B 43.84B 2,896B 45.39B 310B 123B 1,547B 115B 113B 4,907B EV / Sales 2026 *
5.88x
EV / Sales 2027 * 5.23x
Free-Float
90.14%
Yield 2026 *
-
Yield 2027 * -
1 day+2.38%
1 week-1.34%
Current month+1.26%
1 month-3.01%
3 months-8.23%
6 months+36.29%
Current year+25.55%
1 week 78.93
Extreme 78.93
83.66
1 month 76.52
Extreme 76.52
90.25
Current year 56.72
Extreme 56.72
92.59
1 year 56.72
Extreme 56.72
92.59
3 years 54.11
Extreme 54.11
142
5 years 54.11
Extreme 54.11
164.86
10 years 10.66
Extreme 10.655
164.86
Manager TitleAgeSince
Chief Executive Officer 47 2025-12-31
Director of Finance/CFO 46 2021-03-18
Chief Tech/Sci/R&D Officer - 2024-04-30
Director TitleAgeSince
Chairman 68 2018-07-29
Director/Board Member 67 2009-11-19
Director/Board Member 47 2025-12-31
Date Insider Type Main position Quantity % Market Cap. Importance
10/30/26 Don

Director

-2,389 0.0006%
10/27/26 Sell

Head of Human Resources

-2,565 0.0007%
10/15/26 Sell

Compliance Officer

-1,700 0.0005%
Change 5-day change 1-year change 3-year change Capi.($)
+2.38%-1.34%+39.79%-11.40% 30.35B
+1.18%-4.47%-15.76%+15.48% 186B
+1.85%-1.89%+7.36%+45.53% 124B
-0.88%-7.59%-15.71%+13.16% 119B
+1.36%-5.00%-43.14%+4.26% 91.43B
+2.96%+5.70%-1.21%+81.72% 66.67B
+1.08%+2.10%+13.49%-7.08% 58.76B
+0.89%+5.00%-1.31%+64.26% 54.99B
-0.68%-0.62%-2.41%+56.27% 49.93B
-1.28%-0.73% - - 35.13B
Average +0.64%-2.14%-2.10%+29.13% 82B
Weighted average by Cap. +0.57%-3.38%-7.82%+27.54%

Financials

2026 *2027 *
Net sales 5.23B 4.74B 4.38B 3.96B 7.46B 493B 7.72B 52.66B 20.88B 263B 19.62B 19.2B 835B 5.77B 5.24B 4.84B 4.37B 8.24B 544B 8.53B 58.17B 23.06B 291B 21.67B 21.21B 922B
Net income 980M 889M 821M 742M 1.4B 92.33B 1.45B 9.87B 3.91B 49.33B 3.68B 3.6B 156B 1.14B 1.04B 958M 865M 1.63B 108B 1.69B 11.51B 4.56B 57.54B 4.29B 4.2B 183B
Net Debt -343M -312M -288M -260M -490M -32.37B -507M -3.46B -1.37B -17.29B -1.29B -1.26B -54.85B -888M -805M -744M -672M -1.27B -83.64B -1.31B -8.94B -3.54B -44.69B -3.33B -3.26B -142B
Projected Income Statement - Annual - DexCom, Inc.
Logo DexCom, Inc.
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.5% of net sales.
Employees
11,050
Date Price Change Volume
26-11-13 $83.32 +2.37% 2,975,024
26-11-12 $81.39 +1.30% 4,087,159
26-11-11 $80.35 +0.53% 3,231,228
26-11-10 $79.92 -1.42% 3,098,780
26-11-09 $81.07 +2.09% 4,099,334
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - DexCom, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
29
Last Close Price
81.39USD
Average target price
98.58USD
Spread / Average Target
+21.12%
  1. Stock Market
  2. Stocks
  3. DXCM Stock